Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.
Read Full NewsNeurologist Indu Subramanian and migraine expert Andrew Charles discuss the risk for stroke in patients with migraine.
A man with a prior below-knee amputation develops progressive stump pain, and vascular imaging reveals an unexpected arterial blockage that is still treatable.
What belongs to medicine, and what belongs to the machine? Dr Travis Bias argues that AI must augment — not replace — human connection in clinical care.
Dr Lily Brown explains why GAD is often underdiagnosed and how overreliance on depression labels and the GAD-7 alone can miss key anxiety disorders.
Dr Raghda Rashad argues that screening for occupational history could keep more women in the workforce, but most clinicians never ask.
Extreme heat is already increasing deaths, worsening chronic diseases, and widening health inequalities, as clinicians face growing pressure to prepare for a hotter future.
The Ebola outbreak in Congo has not yet stabilised and is still expanding as population movement fuels transmission, a World Health Organization official said on...
1.
NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.
2.
Mortality up for children with leukemia from lowest SES neighborhoods
3.
The most precise research tools for the deadliest blood cancer have been developed.
4.
Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer
5.
Discovery of breast cancer treatment resistance mechanism could lead to new hope for some
1.
The Crucial Role of Antithrombin 3 in Preventing Blood Clots: A Comprehensive Guide
2.
Virtual Oncology Care Continuums: Transforming Cancer Management Through Digital Innovation
3.
Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment
4.
Ferroptosis in Cancer Therapy: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
5.
Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
2.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
3.
Navigating the Complexities of Ph Negative ALL - Part XIV
4.
Thromboprophylaxis In Medical Settings
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge